[Anticonvulsive properties of hemithiamine].
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001534:Bemegride / Q000506:poisoning; D002540:Cerebral Cortex / Q000187:drug effects*; D005260:Female; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008297:Male; D051379:Mice; D010277:Parasympathomimetics / Q000037:antagonists & inhibitors; D010433:Pentylenetetrazole / Q000506:poisoning; D051381:Rats; D012663:Semicarbazides / Q000506:poisoning; D013331:Strychnine / Q000037:antagonists & inhibitors; D013844:Thiazoles / Q000494:pharmacology*; D014149:Tranquilizing Agents / Q000494:pharmacology*
D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D010277:Parasympathomimetics; D012663:Semicarbazides; D013844:Thiazoles; D014149:Tranquilizing Agents; D001534:Bemegride; D013331:Strychnine; D010433:Pentylenetetrazole
Protivosudorozhnye svoĭstva gemitiamina.